Interested? Contact Us
Chinese drugmaker Chipscreen's STAR Market IPO sees feverish demand
Shenzhen Chipscreen Biosciences, which plans to list on China's red-hot new tech board, said its newly issued shares were almost 3,000-times oversubscribed among retail investors, despite an eye-popping offer pricing of 468-times earnings.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
